0000000000872503

AUTHOR

Alessandro Gullotti

showing 6 related works from this author

Trattamento immunomodulante delle lesioni pre-cancerose della cervice uterina ( LSIL ) con beta-glucani

2014

Il tumore della cervice uterina rappresenta oggi l'esempio più eclatante di neoplasia associata a fattori immunologici. Uno dei fattori di rischio principali di tale malattia è, infatti, l'infezione da HPV ( Human papillomavirus). L'incidenza di tale infezione risulta essere direttamente proporzionale all'entità della lesione neoplastica arrivando a toccare quota 89% nel cancro invasivo della cervice. Lo scopo del nostro lavoro è stato quello di osservare come un aumento della risposta immunitaria cellulo-mediata indotta dai Beta-glucani possa influenzare la risoluzione delle lesioni precancerose di basso grado della cervice uterina ( LSIL ). Sono state prese in considerazione, dal 2009 al …

beta-glucaniSettore MED/18 - Chirurgia Generale
researchProduct

Atherosclerosis, inflammation and Chlamydia pneumoniae

2009

Coronary heart disease is the single most common cause of illness and death in the developed world. Coronary atherosclerosis is by far the most frequent cause of ischemic heart disease, and plaque disruption with superimposed thrombosis is the main cause of the acute coronary syndromes of unstable angina, myocardial infarction, and sudden death. Atherosclerosis is the result of a complex interaction between blood elements, disturbed flow, and vessel wall abnormality, involving several pathological processes: inflammation, with increased endothelial permeability, endothelial activation, and monocyte recruitment; growth, with smooth muscle cell proliferation, migration, and matrix synthesis; …

medicine.medical_specialtyPathologyATHEROSCLEROSIS INFECTIONUnstable anginabusiness.industryInflammationChlamydia Coronary atherosclerosis Coronary heart disease PhlogosisReviewmedicine.diseaseSudden deathThrombosisEndothelial activationInternal medicinemedicineCardiologyMyocardial infarctionmedicine.symptomCardiology and Cardiovascular MedicinebusinessCoronary atherosclerosisCalcification
researchProduct

The PFO anatomy evaluation as possible tool to stratify the associated risks and the benefits arising from the closure

2010

Aims According to the current guidelines, the patent foramen ovale (PFO) is still considered a qualitative factor and, as a consequence, its closure is recommended just on the basis of its ‘presence’. Methods and results In the year 2008, we evaluated 25 patients (mean age 62.7) with acute cerebrovascular event and 92 patients (mean age 27.3) suffering from migraine with aura. No PFO was reported in 79 patients. A venous-to-arterial circulation shunt had been shown in 38 patients (29 subjects with migraine and 9 subjects with prior stroke). According to the number of microbubbles arrived during the Valsava manoeuvre, we found: 25 small PFO, 6 moderate PFO, and 6 severe PFO. In the baseline …

AdultMalemedicine.medical_specialtyValsalva ManeuverMigraine with AuraPopulationForamen Ovale PatentRisk AssessmentBrain IschemiaRisk FactorsIschaemic strokeConfidence IntervalsOdds RatiomedicineForamenHumansRadiology Nuclear Medicine and imagingeducationeducation.field_of_studybusiness.industryMean ageGeneral MedicineMiddle AgedPrognosismedicine.diseaseSettore MED/11 - Malattie Dell'Apparato CardiovascolareMigraine with auraSurgeryItalyMigraineEchocardiographyCase-Control StudiesMultivariate AnalysisIschemic strokePatent foramen ovaleFemalePFOevaluationmedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Noncompaction of the Right Ventricle

2010

Noncompaction of the ventricular myocardium is a disease characterized by an increase of the ventricular trabecular meshwork caused by arrest of the normal endomyocardial morphogenesis (Figs. 1, 2, 3). In accordance with the normal human anatomy, the left ventricular wall is well compacted with a few thin trabeculae; on the contrary, the normal right ventricular wall is furrowed by many trabeculae (the trabecula of the marginal septum as well as other ones). For this reason, the term ‘‘noncompaction’’ usually refers to an exclusive or prevalent disease of the left ventricle [1–16]. Recently Song and Aragona et al. [1–3] reported two cases of isolated right-ventricular noncompaction. Accordi…

Marginal septummedicine.medical_specialtyHeart Ventriclesright ventricleDiagnosis DifferentialTrabeculamedicineHumansnoncompactioncardiovascular diseasesChildIsolated Noncompaction of the Ventricular Myocardiumbusiness.industryMyocardiumVentricular wallRight ventricular infarctionAnatomyMagnetic Resonance ImagingCardiac surgeryDeath Sudden Cardiacmedicine.anatomical_structureEchocardiographyVentricleChild PreschoolPediatrics Perinatology and Child HealthHuman anatomycardiovascular systemTrabecular meshworkCardiology and Cardiovascular MedicinebusinessEndocardiumPediatric Cardiology
researchProduct

Management of uncomplicated arterial hypertension in pregnancy

2006

researchProduct

Protrhombotic Effects of Contraceptives

2010

The use of oral contraceptives first became widespread some 40 years ago, and reports of an excess risk of cardiovascular disease among women who used these agents soon followed. Few drugs have been the object of such intensive epidemiological research, the outcome of which has provided clinicians with detailed information about risks not only of specific thrombotic diseases but also important non-contraceptive benefits from the pill. Recently, oral contraceptives have been classified by some according to "generation" (first, second, third, and most recently, fourth generation): first-generation formulations containing lynestrenol or norethindrone, second-generation formulations containing …

medicine.medical_specialtymedicine.drug_classLipid Metabolism DisordersMyocardial InfarctionPhysiologyGestodeneRisk AssessmentRisk FactorsDesogestrelInternal medicineDrug DiscoverymedicineHumansLevonorgestrelGlucose Metabolism DisordersVenous ThrombosisPharmacologyHemostasisbusiness.industryModels CardiovascularAtherosclerosisLipid MetabolismNorgestimateSettore MED/11 - Malattie Dell'Apparato CardiovascolareLynestrenolEndocrinologyEstrogenPillHypertensionFemaleRisk assessmentbusinessTrhombosis contraceptivesContraceptives Oralmedicine.drugCurrent Pharmaceutical Design
researchProduct